| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,241 |
18,795 |
$984K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,215 |
13,260 |
$441K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
244 |
210 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
325 |
254 |
$10K |
| 90688 |
|
940 |
894 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
465 |
439 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
77 |
68 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
555 |
377 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
245 |
192 |
$4K |
| 81003 |
|
2,986 |
2,553 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
540 |
455 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
28 |
27 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
107 |
77 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
17 |
14 |
$941.98 |
| 99499 |
|
12 |
12 |
$108.00 |
| 93000 |
|
12 |
12 |
$104.56 |
| 84703 |
|
23 |
13 |
$89.64 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
12 |
$85.88 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
29 |
29 |
$27.54 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
68 |
61 |
$25.85 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
13 |
$0.85 |
| G0008 |
Administration of influenza virus vaccine |
431 |
372 |
$0.00 |
| 1000F |
|
53 |
51 |
$0.00 |
| G2197 |
Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user |
132 |
96 |
$0.00 |
| 1036F |
|
59 |
56 |
$0.00 |
| 3008F |
|
41 |
39 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
15 |
13 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
14 |
12 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
66 |
66 |
$0.00 |
| 90662 |
|
14 |
14 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
133 |
96 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
29 |
19 |
$0.00 |
| 1159F |
|
55 |
53 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
41 |
33 |
$0.00 |
| 1160F |
|
55 |
53 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
14 |
12 |
$0.00 |